Annual Retained Earnings
-$157.10 M
+$249.70 M+61.38%
31 December 2023
Summary:
Neurocrine Biosciences annual retained earnings is currently -$157.10 million, with the most recent change of +$249.70 million (+61.38%) on 31 December 2023. During the last 3 years, it has risen by +$568.30 million (+78.34%). NBIX annual retained earnings is now -3106.12% below its all-time high of -$4.90 million, reached on 31 December 1997.NBIX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
$81.10 M
+$129.80 M+266.53%
30 September 2024
Summary:
Neurocrine Biosciences quarterly retained earnings is currently $81.10 million, with the most recent change of +$129.80 million (+266.53%) on 30 September 2024. Over the past year, it has increased by +$385.90 million (+126.61%). NBIX quarterly retained earnings is now at all-time high.NBIX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBIX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +61.4% | +126.6% |
| 3 y3 years | +78.3% | +112.9% |
| 5 y5 years | +86.7% | +107.0% |
NBIX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +78.3% | at high | +112.8% |
| 5 y | 5 years | at high | +86.7% | at high | +107.0% |
| alltime | all time | -3106.1% | +86.9% | at high | +106.4% |
Neurocrine Biosciences Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $81.10 M(-266.5%) |
| June 2024 | - | -$48.70 M(-57.2%) |
| Mar 2024 | - | -$113.70 M(-27.6%) |
| Dec 2023 | -$157.10 M(-61.4%) | -$157.10 M(-48.5%) |
| Sept 2023 | - | -$304.80 M(-21.4%) |
| June 2023 | - | -$387.90 M(-19.8%) |
| Mar 2023 | - | -$483.40 M(+18.8%) |
| Dec 2022 | -$406.80 M(-36.0%) | -$406.80 M(-18.0%) |
| Sept 2022 | - | -$495.80 M(-12.1%) |
| June 2022 | - | -$564.30 M(+3.1%) |
| Mar 2022 | - | -$547.40 M(-13.9%) |
| Dec 2021 | -$635.80 M(-12.4%) | -$635.80 M(+1.2%) |
| Sept 2021 | - | -$628.50 M(-3.5%) |
| June 2021 | - | -$651.00 M(-6.1%) |
| Mar 2021 | - | -$693.30 M(-4.4%) |
| Dec 2020 | -$725.40 M(-36.0%) | -$725.40 M(-32.4%) |
| Sept 2020 | - | -$1.07 B(+5.7%) |
| June 2020 | - | -$1.02 B(-7.3%) |
| Mar 2020 | - | -$1.10 B(-3.3%) |
| Dec 2019 | -$1.13 B(-3.8%) | -$1.13 B(-2.9%) |
| Sept 2019 | - | -$1.17 B(-4.4%) |
| June 2019 | - | -$1.22 B(-4.0%) |
| Mar 2019 | - | -$1.27 B(+8.0%) |
| Dec 2018 | -$1.18 B(-1.8%) | -$1.18 B(-1.5%) |
| Sept 2018 | - | -$1.20 B(-4.1%) |
| June 2018 | - | -$1.25 B(+0.5%) |
| Mar 2018 | - | -$1.24 B(+3.5%) |
| Dec 2017 | -$1.20 B(+13.5%) | -$1.20 B(-0.6%) |
| Sept 2017 | - | -$1.21 B(+0.9%) |
| June 2017 | - | -$1.19 B(+5.3%) |
| Mar 2017 | - | -$1.13 B(+7.4%) |
| Dec 2016 | -$1.06 B(+15.4%) | -$1.06 B(+4.4%) |
| Sept 2016 | - | -$1.01 B(+3.8%) |
| June 2016 | - | -$974.78 M(+4.3%) |
| Mar 2016 | - | -$934.50 M(+2.1%) |
| Dec 2015 | -$915.23 M(+10.8%) | -$915.23 M(+3.3%) |
| Sept 2015 | - | -$885.92 M(+4.0%) |
| June 2015 | - | -$851.48 M(+2.9%) |
| Mar 2015 | - | -$827.50 M(+0.1%) |
| Dec 2014 | -$826.30 M(+7.9%) | -$826.30 M(+2.4%) |
| Sept 2014 | - | -$806.86 M(+2.0%) |
| June 2014 | - | -$790.99 M(+1.7%) |
| Mar 2014 | - | -$777.61 M(+1.5%) |
| Dec 2013 | -$765.76 M(+6.4%) | -$765.76 M(+1.4%) |
| Sept 2013 | - | -$755.12 M(+1.5%) |
| June 2013 | - | -$743.99 M(+1.7%) |
| Mar 2013 | - | -$731.75 M(+1.7%) |
| Dec 2012 | -$719.67 M(-0.7%) | -$719.67 M(-1.3%) |
| Sept 2012 | - | -$729.16 M(+0.4%) |
| June 2012 | - | -$726.09 M(+0.1%) |
| Mar 2012 | - | -$725.58 M(+0.1%) |
| Dec 2011 | -$724.70 M(-4.9%) | -$724.70 M(-0.2%) |
| Sept 2011 | - | -$726.03 M(-4.1%) |
| June 2011 | - | -$757.41 M(-0.3%) |
| Mar 2011 | - | -$759.39 M(-0.4%) |
| Dec 2010 | -$762.27 M | -$762.27 M(-0.3%) |
| Sept 2010 | - | -$764.76 M(-0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2010 | - | -$768.09 M(+0.7%) |
| Mar 2010 | - | -$762.94 M(+1.1%) |
| Dec 2009 | -$754.30 M(+7.3%) | -$754.30 M(+1.1%) |
| Sept 2009 | - | -$746.38 M(+1.1%) |
| June 2009 | - | -$738.21 M(+2.1%) |
| Mar 2009 | - | -$722.93 M(+2.8%) |
| Dec 2008 | -$703.26 M(+14.4%) | -$703.26 M(+4.3%) |
| Sept 2008 | - | -$674.41 M(+2.7%) |
| June 2008 | - | -$656.70 M(+3.3%) |
| Mar 2008 | - | -$635.73 M(+3.4%) |
| Dec 2007 | -$614.65 M(+50.9%) | -$614.65 M(+26.3%) |
| Sept 2007 | - | -$486.68 M(+5.9%) |
| June 2007 | - | -$459.44 M(+6.1%) |
| Mar 2007 | - | -$433.07 M(+6.3%) |
| Dec 2006 | -$407.35 M(+35.7%) | -$407.35 M(+3.7%) |
| Sept 2006 | - | -$392.64 M(+11.1%) |
| June 2006 | - | -$353.50 M(+8.4%) |
| Mar 2006 | - | -$326.05 M(+8.6%) |
| Dec 2005 | -$300.15 M(+8.0%) | -$300.15 M(+8.7%) |
| Sept 2005 | - | -$276.24 M(-8.6%) |
| June 2005 | - | -$302.39 M(+1.9%) |
| Mar 2005 | - | -$296.79 M(+6.8%) |
| Dec 2004 | -$277.95 M(+19.7%) | -$277.95 M(+8.0%) |
| Sept 2004 | - | -$257.34 M(+0.6%) |
| June 2004 | - | -$255.69 M(+4.6%) |
| Mar 2004 | - | -$244.56 M(+5.3%) |
| Dec 2003 | -$232.18 M(+15.0%) | -$232.18 M(-1.4%) |
| Sept 2003 | - | -$235.38 M(+4.4%) |
| June 2003 | - | -$225.54 M(+4.7%) |
| Mar 2003 | - | -$215.32 M(+6.6%) |
| Dec 2002 | -$201.93 M(+88.0%) | -$201.93 M(+23.8%) |
| Sept 2002 | - | -$163.14 M(+14.2%) |
| June 2002 | - | -$142.91 M(+16.0%) |
| Mar 2002 | - | -$123.15 M(+14.7%) |
| Dec 2001 | -$107.39 M(+52.4%) | -$107.39 M(+15.7%) |
| Sept 2001 | - | -$92.78 M(-2.6%) |
| June 2001 | - | -$95.29 M(+16.3%) |
| Mar 2001 | - | -$81.94 M(+16.3%) |
| Dec 2000 | -$70.48 M(+69.0%) | -$70.48 M(+15.5%) |
| Sept 2000 | - | -$61.05 M(+15.4%) |
| June 2000 | - | -$52.91 M(+10.9%) |
| Mar 2000 | - | -$47.72 M(+14.4%) |
| Dec 1999 | -$41.70 M(+67.5%) | -$41.70 M(+9.7%) |
| Sept 1999 | - | -$38.00 M(+13.4%) |
| June 1999 | - | -$33.50 M(+15.9%) |
| Mar 1999 | - | -$28.90 M(+16.1%) |
| Dec 1998 | -$24.90 M(+408.2%) | -$24.90 M(+37.6%) |
| Sept 1998 | - | -$18.10 M(+28.4%) |
| June 1998 | - | -$14.10 M(+131.1%) |
| Mar 1998 | - | -$6.10 M(+24.5%) |
| Dec 1997 | -$4.90 M(-51.0%) | -$4.90 M(-2.0%) |
| Sept 1997 | - | -$5.00 M(-13.8%) |
| June 1997 | - | -$5.80 M(-1.7%) |
| Mar 1997 | - | -$5.90 M(-41.0%) |
| Dec 1996 | -$10.00 M | -$10.00 M(-31.0%) |
| Sept 1996 | - | -$14.50 M(+2.8%) |
| June 1996 | - | -$14.10 M(-11.3%) |
| Mar 1996 | - | -$15.90 M |
FAQ
- What is Neurocrine Biosciences annual retained earnings?
- What is the all time high annual retained earnings for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual retained earnings year-on-year change?
- What is Neurocrine Biosciences quarterly retained earnings?
- What is the all time high quarterly retained earnings for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly retained earnings year-on-year change?
What is Neurocrine Biosciences annual retained earnings?
The current annual retained earnings of NBIX is -$157.10 M
What is the all time high annual retained earnings for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual retained earnings is -$4.90 M
What is Neurocrine Biosciences annual retained earnings year-on-year change?
Over the past year, NBIX annual retained earnings has changed by +$249.70 M (+61.38%)
What is Neurocrine Biosciences quarterly retained earnings?
The current quarterly retained earnings of NBIX is $81.10 M
What is the all time high quarterly retained earnings for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly retained earnings is $81.10 M
What is Neurocrine Biosciences quarterly retained earnings year-on-year change?
Over the past year, NBIX quarterly retained earnings has changed by +$385.90 M (+126.61%)